✓ Translated by DotMD AI Clinical Council Source: FDA MedWatch Safety Alerts • FDA Safety Alert
Verify Primary Source: NIH PubMed PMID #FDA_MEDWATCH-3554589851 ↗

FDA MedWatch Safety Alerts (Safety Alert): Wedgewood Pharmacy Issues Recall of Certain Compounded Veterinary Medications Within Expiry Due to Potential Potency Issues

Original Paper Title: “Wedgewood Pharmacy Issues Recall of Certain Compounded Veterinary Medications Within Expiry Due to Potential Potency Issues”

Elena Rostova (AI Quant) Rigor Score
95 / 100
Sample Size (Participants)
Systematic Review
Evidence Classification
FDA Safety Alert
Sarah Jenkins, RN (AI Plain-English Editor) • Key Takeaways
  • SWEDESBORO, N.J., (October 21, 2026) - Wedgewood Pharmacy LLC ("Wedgewood") is recalling certain compounded veterinary medications within expiry at the provider/customer level due to inconsistencies in the reliability of certain analytical testing data generat
  • Study Design & Sample: FDA Safety Alert published in FDA MedWatch Safety Alerts (Multi-cohort synthesis).
  • Biostatistical Rigor Score: 95/100 audited by Elena Rostova (AI Biostatistician & openFDA Quant).

What the Study Found (In Plain English)

SWEDESBORO, N.J., (October 21, 2026) - Wedgewood Pharmacy LLC ("Wedgewood") is recalling certain compounded veterinary medications within expiry at the provider/customer level due to inconsistencies in the reliability of certain analytical testing data generated by their laboratory, potentially resu Indexed from FDA MedWatch Safety Alerts (2026-10-21) by DotMD's 2-hour clinical surveillance pipeline.

Dr. Lin (AI Evidence Lead): Statistical Endpoints & Numbers

Primary Endpoint & Quantitative Summary (FDA MedWatch Safety Alerts, 2026-10-21; FDA Safety Alert; Rigor 95/100): SWEDESBORO, N.J., (October 21, 2026) - Wedgewood Pharmacy LLC ("Wedgewood") is recalling certain compounded veterinary medications within expiry at the provider/customer level due to inconsistencies in the reliability of certain analytical testing data generat

Study Limitations & Caveats Before You Act

Clinical trials evaluate specific inclusion/exclusion cohorts under protocol-controlled conditions (FDA Safety Alert). Individual response, hepatic/renal clearance, CYP450 drug interactions, and baseline comorbidities vary; verify applicability with a board-certified physician before modifying any prescription or supplement regimen.

Transparent AI Research Council • Grounded on NIH / FDA / PubMed Data

Ask our AI Specialists anything about PMID FDA_MEDWATCH-3554589851: FDA MedWatch Safety Alerts (Safety Alert): Wedgewood Pharmacy Issues Recall of Certain Compounded Veterinary Medications Within Expiry Due to Potential Potency Issues

3 of 3 Free Questions Remaining